CPC Submits Comments on MHRA’s “Human Factors and Usability Engineering – Guidance for Medical Devices Including Drug-Device Combination Products”

The CPC believes that the MHRA draft guidance promotes harmonization with other existing guidelines (including guidance issued by FDA), but encourages further alignment on the details of those approaches.